Advertisement
Canada markets open in 4 hours 25 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7328
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    83.71
    +0.14 (+0.17%)
     
  • Bitcoin CAD

    87,980.02
    +746.97 (+0.86%)
     
  • CMC Crypto 200

    1,389.57
    -6.96 (-0.50%)
     
  • GOLD FUTURES

    2,359.80
    +17.30 (+0.74%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,733.00
    +165.50 (+0.94%)
     
  • VOLATILITY

    15.55
    +0.18 (+1.17%)
     
  • FTSE

    8,109.35
    +30.49 (+0.38%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6821
    0.0000 (0.00%)
     

2 Reasons This Stock Could Outperform in 2023

2 Reasons This Stock Could Outperform in 2023

Biotech giant Gilead Sciences (NASDAQ: GILD) is a member of this elite club, having seen its shares rise by 15% year to date. Let's consider two reasons why Gilead Sciences is worth serious consideration heading into the new year. Gilead Sciences' most important unit by some margin remains its HIV business.